Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.

Monson KR, Ferguson R, Handzlik JE, Morales L, Xiong J, Chat V, Dagayev S, Khodadadi-Jamayran A, Simpson D, Kazlow E, Bunis A, Sreenivasaiah C, Ibrahim M, Voloshyna I, Ouwerkerk W, Luiten RM, Capone M, Madonna G, Lu Y, Shao Y, Pavlick A, Krogsgaard M, Mehnert J, Tang H, Dolfi S, Tenney D, Haanen JBAG, Gajewski TF, Hodi FS, Flaherty KT, Couts K, Robinson W, Puzanov I, Ernstoff MS, Rahma O, Postow M, Sullivan RJ, Luke JJ, Ascierto PA, IO-GEM Consortium, Osman I, Kirchhoff T

Open source

DOI
10.1038/s41591-025-03699-3
Published
2025 Jul
Container
Nature medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-025-03699-3,
  title = {Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.},
  author = {Monson KR and Ferguson R and Handzlik JE and Morales L and Xiong J and Chat V and Dagayev S and Khodadadi-Jamayran A and Simpson D and Kazlow E and Bunis A and Sreenivasaiah C and Ibrahim M and Voloshyna I and Ouwerkerk W and Luiten RM and Capone M and Madonna G and Lu Y and Shao Y and Pavlick A and Krogsgaard M and Mehnert J and Tang H and Dolfi S and Tenney D and Haanen JBAG and Gajewski TF and Hodi FS and Flaherty KT and Couts K and Robinson W and Puzanov I and Ernstoff MS and Rahma O and Postow M and Sullivan RJ and Luke JJ and Ascierto PA and IO-GEM Consortium and Osman I and Kirchhoff T},
  year = {2025},
  journal = {Nature medicine},
  doi = {10.1038/s41591-025-03699-3},
  url = {https://doi.org/10.1038/s41591-025-03699-3}
}

RIS

TY  - JOUR
TI  - Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.
AU  - Monson KR
AU  - Ferguson R
AU  - Handzlik JE
AU  - Morales L
AU  - Xiong J
AU  - Chat V
AU  - Dagayev S
AU  - Khodadadi-Jamayran A
AU  - Simpson D
AU  - Kazlow E
AU  - Bunis A
AU  - Sreenivasaiah C
AU  - Ibrahim M
AU  - Voloshyna I
AU  - Ouwerkerk W
AU  - Luiten RM
AU  - Capone M
AU  - Madonna G
AU  - Lu Y
AU  - Shao Y
AU  - Pavlick A
AU  - Krogsgaard M
AU  - Mehnert J
AU  - Tang H
AU  - Dolfi S
AU  - Tenney D
AU  - Haanen JBAG
AU  - Gajewski TF
AU  - Hodi FS
AU  - Flaherty KT
AU  - Couts K
AU  - Robinson W
AU  - Puzanov I
AU  - Ernstoff MS
AU  - Rahma O
AU  - Postow M
AU  - Sullivan RJ
AU  - Luke JJ
AU  - Ascierto PA
AU  - IO-GEM Consortium
AU  - Osman I
AU  - Kirchhoff T
PY  - 2025
JO  - Nature medicine
DO  - 10.1038/s41591-025-03699-3
UR  - https://doi.org/10.1038/s41591-025-03699-3
ER  - 

APA

KR, M., R, F., JE, H., L, M., J, X., V, C., S, D., A, K., D, S., E, K., A, B., C, S., M, I., I, V., W, O., RM, L., M, C., G, M., Y, L., Y, S., A, P., M, K., J, M., H, T., S, D., D, T., JBAG, H., TF, G., FS, H., KT, F., K, C., W, R., I, P., MS, E., O, R., M, P., RJ, S., JJ, L., PA, A., Consortium, I., I, O., & T, K. (2025). Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.. Nature medicine. https://doi.org/10.1038/s41591-025-03699-3

Source records